C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/2001
11/07/2001	EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
11/07/2001	CN1321168A Laundry detergent and/or fabric care compositions comprising modified antimicrobial protein
11/07/2001	CN1321165A Prevention and treatment of viral disease
11/07/2001	CN1321064A Plant resistance to insect pests medicated by viral proteins
11/07/2001	CN1074422C Method for preparing HCV epitope-contg. separated polypeptide
11/06/2001	US6313263 γ, δ T cell receptor and methods for detection
11/06/2001	US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases
11/06/2001	US6312923 Method for expression of heterologous proteins in yeast
11/06/2001	US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081426A2 Rgd (arg-gly-asp) coupled to (neuro)peptides
11/01/2001	WO2001081417A2 Use of taci as an anti-tumor agent
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	WO2001081405A2 Methods and compositions for the prevention and treatment of anemia
11/01/2001	WO2001081400A1 Nk-2 homeobox transcription factor
11/01/2001	WO2001081377A2 Integrin/adhesion antagonists
11/01/2001	WO2001042306A3 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	US20010036911 Detergent compositions comprising benefit agents
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	CA2690018A1 Methods and compositions for the prevention and treatment of anemia
11/01/2001	CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001	CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	CA2407086A1 Integrin/adhesion antagonists
11/01/2001	CA2406839A1 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	CA2405985A1 Nk-2 homeobox transcription factor
10/2001
10/31/2001	EP1149913A1 Cytokine immunoconjugates
10/31/2001	EP1149168A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
10/31/2001	EP1149114A2 Polypeptides involved in immune response
10/31/2001	EP1148782A2 Plant resistance to insect pests mediated by viral proteins
10/31/2001	EP0699077B1 Hiv immunogenic complexes
10/30/2001	US6310184 Immunoglobulin for the treatment and prevention of mammary and prostate gland cancers
10/30/2001	US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001	US6309648 Induces formation of protective antibodies against an infection by a bacteria selected from the group consisting of b. pertussis, b. parapertussis, and b. bronchiseptica when administered to a human or animal host.
10/30/2001	US6309645 A method of suppressing an immune response in a mammal.
10/30/2001	CA2093643C Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
10/25/2001	WO2001079493A1 New lipid binding protein 2
10/25/2001	WO2001079492A2 Lipid binding protein 3
10/25/2001	WO2001079480A1 Albumin fusion proteins
10/25/2001	WO2001079468A2 Drug metabolizing enzymes
10/25/2001	WO2001079448A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001	WO2001079444A2 Albumin fusion proteins
10/25/2001	WO2001079443A2 Albumin fusion proteins
10/25/2001	WO2001079442A2 Albumin fusion proteins
10/25/2001	WO2001079291A2 Secreted proteins
10/25/2001	WO2001079286A2 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001	WO2001079271A1 Albumin fusion proteins
10/25/2001	WO2001079269A2 Lipid binding protein 4
10/25/2001	WO2001079259A1 Javelinization of protein antigens to heat shock proteins
10/25/2001	WO2001079258A1 Albumin fusion proteins
10/25/2001	WO2001078772A1 Heat shock protein-based antiviral vaccines
10/25/2001	WO2001078768A2 Targeted vaccine delivery systems
10/25/2001	WO2001078655A2 Methods and compositions for heat shock protein mediated immunotherapy of melanoma
10/25/2001	WO2001078503A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001	WO2001027159A3 Polypeptides for detection and elimination of ca19-9 antigen positive cells
10/25/2001	WO2001023421A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
10/25/2001	WO2001012663A3 Hematopoietic regulatory factors and methods of use thereof
10/25/2001	US20010034324 Immunostimulation
10/25/2001	US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2
10/25/2001	CA2747325A1 Albumin fusion proteins
10/25/2001	CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001	CA2406472A1 Javelinization of protein antigens to heat shock proteins
10/25/2001	CA2406378A1 Targeted vaccine delivery systems
10/25/2001	CA2406213A1 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001	CA2406195A1 Lipid binding protein 4
10/25/2001	CA2406087A1 New lipid binding protein 2
10/25/2001	CA2406066A1 Lipid binding protein 3
10/25/2001	CA2405781A1 Secreted proteins
10/25/2001	CA2405753A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/24/2001	EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
10/24/2001	EP1147190A1 Her-2/neu fusion proteins
10/24/2001	EP1147133A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
10/24/2001	EP1146889A2 Identification of specific differentially expressed mycobacterial antigens
10/24/2001	CN1319140A Recombinant CELO virus and CELO virus DNA
10/24/2001	CN1319105A Methods for produsction of antibodies to specific regions of cyclosporine and cyclosporine metabolites
10/23/2001	US6306663 Controlling protein levels in eucaryotic organisms
10/23/2001	US6306654 Nucleotide sequence coding mutant gonadotrophin hormone; for treatment of reproduction defects
10/23/2001	US6306583 Human brain phosphodiesterase
10/23/2001	US6306580 Preparation of human papillomavirus E1 having helicase activity and method therefor
10/23/2001	US6306402 Compounds and methods for the diagnosis and treatment of EHRLICHIA infection
10/23/2001	US6306397 Variants of human papilloma virus antigens
10/18/2001	WO2001077676A1 T2r taste receptors and genes encoding same
10/18/2001	WO2001077342A1 Multivalent antibodies and uses therefor
10/18/2001	WO2001077340A1 Identification of a dual specificity phosphatase: dusp-10
10/18/2001	WO2001077339A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	WO2001077322A1 Cryptic-like secreted protein
10/18/2001	WO2001077321A2 Identification of a human gaba transporter
10/18/2001	WO2001077179A1 Proteins with a high immunoreactivity and a method for the production thereof
10/18/2001	WO2001077158A1 Hepatitis b core antigen fusion proteins
10/18/2001	WO2001077150A2 Serine-threonine kinase
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077148A2 Human lipid binding protein 1

1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 295